Business · Companies · 6 hrs ago

Singapore seeks commercial success from its growing pharmaceutical sector

Singapore seeks commercial success from its growing pharmaceutical sector

Singapore has attracted eight of the world’s top 10 drug makers as it works to become Southeast Asia’s leading biomedicine hub.

Experts say it needs commercially successful medicines to turn its scientific strengths into lasting gains.

The city state’s small home market and rising competition for investment are challenges.

Industry insiders say Singapore could become a gateway for Chinese medicines and a regional centre for rare-disease care.

Bayer hopes Singapore will be among the first places to approve its new blood thinner asundexian, which is intended to prevent repeat strokes.

China approved the medicine last month, and Bayer said on November 9 that the United States had also approved it.

1 source

Related